Skip to main content
OpenTrials

Clinical trial condition

Germline BRCA1/2 Mutations

Explore clinical trials studying Germline BRCA1/2 Mutations. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Germline BRCA1/2 Mutations trial results

Completed

To Study Clinical Effectiveness and Safety of Olaparib Monotherapy in Metastatic Breast Cancer Patients.

NCT03286842

Conditions
Germline BRCA1/2 Mutations, HER2-ve Metastatic Breast Cancer, Somatic BRCA1/2 Mutations
Locations
  • Research Site Towson, Maryland, United States
  • Research Site Jackson, Mississippi, United States
  • Research Site Plovdiv, Bulgaria
  • Research Site Sofia, Bulgaria
View all 123 locations
View Trial Details

Related conditions